Ph D from UW-Milwaukee
Dr. Jin Li joined 3E Bioventures in 2015 as a partner and expertise in new drug research and development area.
Dr. Jin Li returned to China in 2006 co-founded and founded Shenogen, Orbiepharm and Pharmacodia. He also have a strong publication track record. Publishing more than 40 patents, 30 research articles and 14 book chapters.
From 1999 to 2006, Dr. Li worked in Pfizer global r&d of United States headquarter as a principle scientist.
Dr. Jin Li obtained his Ph.D from UW-Milwaukee in 1999.